Latest Europe News

Energy Transition Minerals Ltd (ETM) confronts unexpected uncertainty as Greenlandic authorities signal potential non-extension of the Kvanefjeld exploration licence, disrupting planned 2026 activities and intensifying ongoing legal disputes.

Bioxyne Ltd has secured a manufacturing agreement with global cannabis giant Aurora Cannabis, marking a major step in its international expansion of pharmaceutical-grade medicinal cannabis products.

St George Mining has partnered with Spain’s Tecnicas Reunidas to test advanced processing technology on its Araxá rare earths, aiming to unlock European markets alongside existing US and Brazilian alliances.

Hastings Technology Metals has acquired a 49% stake in a fully permitted rare earth processing plant in Thailand, aiming to commence production by late 2026. This strategic move offers a lower-cost, near-term production hub with potential to process feedstock from its Yangibana project.

Collins Foods has agreed to transfer 20 of its 27 Australian Taco Bell restaurants to a new partnership involving Taco Bell’s parent company, marking a decisive step in its strategic exit from the brand.

Paradigm Biopharmaceuticals has achieved 50% patient enrolment in its pivotal Phase 3 trial for injectable pentosan polysulfate sodium, advancing steadily towards an interim analysis expected in August 2026.

RocketBoots has secured a significant A$3.3 million activation contract with a leading multinational retailer, marking the start of a global deployment phase that complements its existing SaaS agreement and promises near-term revenue growth.

Genetic Signatures is undertaking a major organisational restructure to cut costs by $5 million and sharpen its commercial focus, aiming to accelerate growth in its diagnostic product offerings.

Cynata Therapeutics has completed the 100-day primary evaluation period for its Phase 2 trial of CYP-001 in acute graft versus host disease, with results expected in June 2026. This milestone marks a critical step for the biotech’s lead cell therapy candidate in a condition with few effective treatments.

EML Payments has appointed Adam Olding as its Global CEO, marking a pivotal step in its EML 2.0 transformation and signalling strengthened leadership to drive growth. Concurrently, regulatory developments around its Australian banking licence application introduce new compliance dynamics.

Ava Risk Group has announced a $7 million strategic investment from US-based Hale Capital to fuel its expansion into the US federal security market and accelerate product development. This partnership aims to position Ava as a global leader in critical infrastructure protection with a strong US presence.

Fortuna Metals Limited (ASX:FUN) reports a major high-grade rutile discovery at its Mkanda project in Malawi, positioning itself to meet rising demand from aerospace and emerging robotics sectors amid a tightening global titanium market.